Vice President, Global Program Lead - Hematology Late Development

Vice President, Global Program Lead for Hematology Late Development accountable for two hematology assets, including a marketed asset for anemia and a CELMoD candidate for sickle cell disease. Leads the Global Program Teams and orchestrates the design and execution of a global integrated development plan from candidate nomination through drug development to launch and commercialization. Develops and inspires a high-performing matrix, maintains cross-functional stakeholder relationships, and inputs to upstream/downstream strategy as new data and competitive insights emerge. Responsibilities include defining the integrated development plan, participating in regulatory filings (NDA/BLA), leading program strategy and commercialization planning, building value propositions with market access considerations, supporting investor relations and public affairs, and integrating market inputs into the development plan to maximize asset value. Contributes to disease-area strategies (e.g., AML), engages with KOLs, and collaborates with Medical Affairs on KOL plans. Demonstrates leadership across global matrix functions, designs clinically differentiating trials, and translates clinical data into evidence for regulatory and commercial strategies. Requires broad understanding of domestic and international issues in the pharmaceutical industry, ability to influence across senior leaders, and track record of delivering large, complex drug development programs and trials.